Yes, there are ongoing studies exploring how COVID-19 affects individuals with asthma and whether the virus may contribute to new asthma-related symptoms. Researchers are studying whether people with asthma experience different COVID-19 outcomes compared to the general population and how infection may influence lung function, airway inflammation, and immune responses. Current studies also focus on whether COVID-19 may worsen asthma control in some individuals, increase respiratory sensitivity, or contribute to more frequent breathing difficulties after recovery. Population studies and clinical follow-ups continue to track asthma patients to better understand long-term respiratory trends after infection.

Scientists are also investigating whether COVID-19 may be linked to new-onset asthma in certain individuals, especially those who develop persistent respiratory symptoms after the illness. Research includes lung function testing, symptom monitoring, and evaluation of airway changes to understand ongoing inflammation and breathing challenges. Another key research area examines the overlap between asthma and long COVID, including symptoms such as chronic cough, shortness of breath, and reduced exercise tolerance. Although knowledge continues to evolve, these ongoing studies aim to improve understanding, guide long-term monitoring, and support better respiratory care for people affected by both asthma and COVID-19.